FDA Investigator Rabin N Ghoshal

Rabin N Ghoshal has inspections in 1 countries as of 06 Oct 2023. Rabin N Ghoshal has collaborated with a combinined 2524 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America
Alexandra B Pitkin, Alison N Stieg, Allen Lou, Amalia C Himaya, Anastasia I Onuorah, Anastasia M Shields, Angela Shepas, Anita R Michael, Anthony A Charity, Anthony R Petriella, Atul J Agrawal, Azza Talaat, Binh T Nguyen, Bowman, Brooke K Higgins, Brooke K Seeman, Bryan A Galvez, Carmen M Faraianu, Caroline H Le, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, Cassandra L Abellard, CDR Ileana Barreto Pettit, Chaltu N Wakijra, Charles L Zhou, Cheryl A Fuhs, Cheryl M Monroe, Christopher D Washington, Christopher M Jenner, Constantin Y Philopoulos, Corrine M Carter, Darren S Morgan, David J Hafner, David L Pearce, David Perkins, Deborah B Nixon, Debra J Bennett, Debra L Pagano, Dennis L Doupnik, Diane T Bargo, Diane T O'brien, Douglas A Campbell, Dr. Gopa Biswas, PhD, Emest F Bizjak, Emily J Orban, Erika V Butler, Geneve M Maxwell, George Pyramides, Guerlain Ulysse, Hala L Selby, Hala Lj Whetstone, Hinh T Nguyen, James M Mason, Janet A Rajan, Jeffrey D Meng, Jennifer A Kemp, Joey V Quitania, John P Mistler, Johnna L Bleem, Jonathan W Chapman, Judy C Nepsa, Julianne C Mccullough, Junho Pak, Junho Park, Karen E D'orazio, Kari M Johansen, Katelyn Astaub Zamperini, Kham Phommachanh, Ko U Min, Kristen D Evans, Krystal O Ogunremi, Kshitij A Patkar, Lawrence J Stringer, Leslie A Paul, Liming Zhang, Linda Thai, Luella J Rossi, Luis A Dasta, Marcus A Ray, Martha Sullivan Mynck, Martha Sullivan Myrick, Massoud Motamed, Megha Vora, Melissa J Garcia, Melissa T Roy, Michael D Garcia, Michael F Skelly, PhD, Michael Gurbarg, Michael Y Philopoulos, Michele Gottshall, Michele L Forster, PhD, Michele M Falchek, Michelle Marsh, Mihaly S Ligmond, Nancy M Espinal, Natalie J Ayoub, Nianna C Burns, Patsy J Domingo, Paula J Bretz, Peter R Lenahan, Pratik S Upadhyay, DDC, Qin Xu, Rebecca E Dombrowski, Regina T Brown, Richard A Abate, Richmond K Yip, Robert B Shibuya, MD, Robert J Maffei, Sam Pepe, Sandra A Boyd, Sandra A Hughes, Sara Jdent Acosta, Sarah M Meng, Sarah M Napier, Sean P Desbrow, Sean R Marcsisin, Sharon K Thoma, PharmD, Sneha Patel, Sneha S Patel, State Agency, Stephen J Koniers, Sumit Sen, Susan F Laska, MS, Tamika White, Tamil Arasu, PhD, Tammy L Chavis, Tara L Stockton, Temar Q Williams, Thanh M Andrews, Thomas E Friel, Thomas J Arista, Toyin B Oladimeji, Tracey Asinjen Wiersma, Truong Xuan Nguyen (Andy), Trushani T Desai, Vashti E Bocker, Vioela J Caze, Virgilio F Pacio, CSO, Vlada Matusovsky, William A Warnick, William D Tingley, William L Bargo, Yi Lin, Yvette Mlacour Davis, Yvonne T Lacour

Rabin N Ghoshal's Documents

Publish Date Document Type Title
March, 2015 FDA 483 Response Johnson & Johnson Consumer, Inc - Form 483R, 2015-04-16
March, 2015 FDA 483 Johnson & Johnson Consumer, Inc - Form 483, 2015-03-27
March, 2015 EIR Johnson & Johnson Consumer, Inc - EIR, 2015-03-27
October, 2007 FDA 483 Merck Sharp & Dohme - Form 483, 2007-10-05
February, 2012 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2012-02-02
February, 2012 EIR Mylan Pharmaceuticals Inc. - EIR, 2012-02-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more